株主・投資家の皆様へ

シェアホルダーサービス

アニュアルレポート
2020 Download
2019 Download
2018 Download
2017 Download
2016 Download
2015 Download
2014 Download
2013 Download
2012 Download
2011 Download
2010 Download

Top ten shareholders

as of 4/19/2021
Top 10 Shareholders Total Shares Owned Holding Percentage
Alvogen Emerging Markets Holdings Ltd. Representative 151,100,000 61.58%
Fuji Pharma Co., Ltd. 4,913,220 2.00%
Lazard Emerging Markets Small Cap Equity Trust 3,397,000 1.38%
Fiera Capital Emerging Markets Fund 2,378,500 0.97%
Lotus’ RSA trust 1,940,000 0.79%
Caisse de depot et placement du Quebec - Van Berkom Golden Dragon Limited as external fund manager 1,341,000 0.55%
JPMorgan Chase Bank N.A. Taipei Branch in custody for Vanguard Total International Stock Index Fund a series of Vanguard Star Funds 1,337,189 0.55%
Vanguard Emerging Markets Stock Index Fund a Series of Vanguard International Equity Index Funds 1,133,000 0.46%
Taiwan Life Insurance Co., Ltd. 1,005,000 0.41%
Wen Wan Tang 824,000 0.34%

IRに関するお問い合わせ

代表

Bjartur Shen
Stratigies and Finance VP
電話:+886 2700 2 5908

営業、仕入れ係とクレームのコンタクト

電話:+886 2700 2 5908
Email:info@lotuspharm.com

代行

Angela Luan
Corporate Finance and Regional Investor Relations Director
電話:+886 2 2700 5908
Email: investor@lotuspharm.com

名義書換代理人
Transfer Agency Department, CTBC Bank Co., Ltd. Share Transfer Agency.
Add: 5F., No. 83, Sec. 1, Chongqing S. Rd., Zhongzheng Dist., Taipei City 100, Taiwan.
TEL: +886 2 6636 5566
薬害相談窓口

Tel: +886 2 2504 8125 Ext:1338/1339
Email: lotus.pv@alvogen.com